{
  "docId": "019de076-e431-717d-85d5-60fbb8c86744",
  "docSlug": "9614dd2dbfdf83d72e770ebfe5753af3",
  "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
  "authorId": "nuvalent",
  "authorName": "Nuvalent",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 20,
  "pageCount": 42,
  "prevPage": 19,
  "nextPage": 21,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 51,
  "notes": "The slide uses a standard oncology 'swimmer' or 'waterfall' plot format to demonstrate drug efficacy across different patient cohorts.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-e431-717d-85d5-60fbb8c86744/20",
  "deckHref": "/decks/019de076-e431-717d-85d5-60fbb8c86744",
  "deckJsonHref": "/decks/019de076-e431-717d-85d5-60fbb8c86744.json",
  "deckAnchorHref": "/decks/019de076-e431-717d-85d5-60fbb8c86744#slide-20",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.8,
        "x": 0.15,
        "y": 0.24
      },
      "kind": "chart",
      "text": "Waterfall plot of tumor response",
      "attrs": null,
      "subkind": "waterfall",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2a176a0c-7ebf-41b7-aa3a-4d833d7e7ed5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.83
      },
      "kind": "disclaimer",
      "text": "Data cut-off: 8 August 2023. Response-evaluable patients with NSCLC. Four response-evaluable patients not shown due to incomplete or missing post-baseline tumor assessments.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1c50c5f0-697b-4759-ac79-78ac39cdcbeb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.1,
        "x": 0.06,
        "y": 0.3
      },
      "kind": "legend",
      "text": "200 mg QD, 150 mg QD, 100 mg QD, 50 mg QD, 25 mg QD, 15 mg QD",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "124c445f-9bee-4e3b-a14d-bc2ccb807133",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.65
      },
      "kind": "table",
      "text": "Dose Level Cohort, Prior ALK TKI, Prior lines chemotherapy, Prior lines anticancer therapy",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cb00847d-6ff9-45c6-a115-22ed9ed46e90",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.65,
        "x": 0.05,
        "y": 0.11
      },
      "kind": "title",
      "text": "Preliminary Activity: Radiographic Tumor Response in Patients With and Without Known ALK Resistance Mutations",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b0e6e14b-8080-48f6-8ae9-3cacd3b47c05",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Waterfall chart",
      "slug": "waterfall-chart",
      "agent": null,
      "layer": "slide",
      "matchId": "b69ff297-f862-4a30-b1d9-f4869506b2b7",
      "evidence": "chart/waterfall: Waterfall plot of tumor response",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "waterfall-plot",
      "slug": null,
      "matchId": "053c9790-e0bc-45ea-b6a8-bf07a4c806dd",
      "evidence": "Standard oncology clinical trial visualization",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 36,
      "from": 17,
      "beatId": "af664db1-d363-4d9c-b782-ebd7f300239a",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Traction",
      "beatSlug": null,
      "evidence": "The deck presents traction and clinical trial data from slides 17 to 36",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 20,
      "from": 17,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "768b9693-f057-40a9-8283-be0c1cfc71ac",
      "evidence": "The deck presents data on the cost of inaction for cancer patients and how Nuvalent's solution addresses this",
      "position": 1,
      "objective": "What is the cost of inaction for cancer patients and how does Nuvalent's solution address this?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}